Literature DB >> 17094815

The effect of antipsychotic treatment on Theory of Mind.

Romina Mizrahi1, Michele Korostil, Sergio E Starkstein, Robert B Zipursky, Shitij Kapur.   

Abstract

BACKGROUND: Deficits in a patient's 'theory of mind' (TOM) have been proposed to lead to psychosis. However, it remains unclear whether TOM deficits constitute a trait- or a state-related deficit and whether they respond to antipsychotic treatment, and also whether the change in TOM and change in psychosis are associated.
METHOD: In the cross-sectional component of this study, 71 patients with psychotic disorders were included and TOM ability was measured using a hinting task in which subjects had to infer real intentions behind indirect speech. In the longitudinal study, a different cohort of 17 drug-free patients were included wherein they received antipsychotic treatment for 6 weeks and the effect on psychotic symptoms and TOM was measured every 2 weeks. Associations between TOM and psychopathology were assessed and a mixed effects model was used to investigate the rate of change over time.
RESULTS: Positive and Negative Syndrome Scale (PANSS) total scores were significantly associated with TOM scores. The hinting task was not associated with positive symptoms but was significantly associated with negative and general symptoms. The longitudinal arm of the study showed that both PANSS positive scores and TOM improved after medication was started, particularly during the first 2 weeks of antipsychotic treatment, but these changes were not associated. The TOM response at 2 weeks of antipsychotic treatment reached similar values to those obtained in the cross-sectional sample.
CONCLUSIONS: Although TOM and psychotic symptoms are related to each other, antipsychotic treatment impacts each independently, suggesting a dissimilar cognitive or neurobiological substrate for the two.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17094815     DOI: 10.1017/S0033291706009342

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  9 in total

1.  Modeling Within-Item Dependencies in Parallel Data on Test Responses and Brain Activation.

Authors:  Minjeong Jeon; Paul De Boeck; Jevan Luo; Xiangrui Li; Zhong-Lin Lu
Journal:  Psychometrika       Date:  2021-01-24       Impact factor: 2.500

Review 2.  Is the PANSS used correctly? a systematic review.

Authors:  Michael Obermeier; Rebecca Schennach-Wolff; Sebastian Meyer; Hans-Jürgen Möller; Michael Riedel; Daniela Krause; Florian Seemüller
Journal:  BMC Psychiatry       Date:  2011-07-18       Impact factor: 3.630

3.  A meta-analysis of mentalizing impairments in adults with schizophrenia and autism spectrum disorder.

Authors:  Yu Sun Chung; Deanna Barch; Michael Strube
Journal:  Schizophr Bull       Date:  2013-05-17       Impact factor: 9.306

4.  Imitation, simulation, and schizophrenia.

Authors:  Sohee Park; Natasha Matthews; Crystal Gibson
Journal:  Schizophr Bull       Date:  2008-05-21       Impact factor: 9.306

Review 5.  Pharmacological Interventions for the MATRICS Cognitive Domains in Schizophrenia: What's the Evidence?

Authors:  Wilhelmina A M Vingerhoets; Oswald J N Bloemen; Geor Bakker; Therese A M J van Amelsvoort
Journal:  Front Psychiatry       Date:  2013-12-04       Impact factor: 4.157

6.  Mentalization-based treatment for psychotic disorder: protocol of a randomized controlled trial.

Authors:  Jonas Weijers; Coriene Ten Kate; Elisabeth Eurelings-Bontekoe; Wolfgang Viechtbauer; Rutger Rampaart; Anthony Bateman; Jean-Paul Selten
Journal:  BMC Psychiatry       Date:  2016-06-08       Impact factor: 3.630

7.  Paliperidone Compared with Haloperidol on the Theory of Mind Tasks in Schizophrenia: A Pilot Trial.

Authors:  Jie Zhong; Hong Zhu; Dongqing Yin; Yanzhe Ning; Sisi Zheng; Yanbo Zhang; Hongxiao Jia
Journal:  Neuropsychiatr Dis Treat       Date:  2021-12-14       Impact factor: 2.570

8.  A systematic review of the effects of psychiatric medications on social cognition.

Authors:  Zoë Haime; Andrew J Watson; Nadia Crellin; Louise Marston; Eileen Joyce; Joanna Moncrieff
Journal:  BMC Psychiatry       Date:  2021-11-29       Impact factor: 3.630

Review 9.  Can antipsychotics improve social cognition in patients with schizophrenia?

Authors:  Katarzyna Kucharska-Pietura; Ann Mortimer
Journal:  CNS Drugs       Date:  2013-05       Impact factor: 5.749

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.